Abstract
ABSTRACTPurposeThe risk of Legionnaires’ disease (LD) is suggested to increase, but the global burden of disease is unknown due to lack of appropriate diagnosis and surveillance systems. In Switzerland, the number of LD cases, captured by the National Notification System for Infectious Diseases, has more than doubled since 2008. The aim of this study is to evaluate disease surveillance data using denominator data i.e. the number of tests performed for Legionella. spp.MethodsWe collected the testing data for Legionella spp. of 14 Swiss diagnostic laboratories and calculated the positivity rate, which is the rate of the number of positive tests to the number of tests performed.ResultsThe number of positive tests increased proportionally to the number of tests performed; hence the positivity remained stable. However, the cause of the increase in test volume is unclear and has a large impact on the interpretation of the positivity curve. Further, the test outcome was found to be dependent on regional determinants and the diagnostic method applied.ConclusionIn concert with the lack of understanding if and at which stage LD is considered in current case management of pneumonia patients, it is difficult to interpret heterogeneities in incidence or underestimation in Switzerland.
Publisher
Cold Spring Harbor Laboratory
Reference37 articles.
1. Legionnaires' Disease
2. PONTIAC FEVER
3. Probable Person-to-Person Transmission of Legionnaires’ Disease
4. Legionnaires’ disease - Annual epidemiological report for 2017. Stockholm: ECDC; 2019.
5. Legionella (Legionnaires’ disease and Pontiac fever): history, burden, and trends. CDC. 2018. https://www.cdc.gov/legionella/about/history.html. Accessed 16 August 2019.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献